Melvyn I Marquis
Examiner (ID: 16161)
Most Active Art Unit | 1501 |
Art Unit(s) | 1402, 1505, 1503, 1501, 1712, 2200, 1754, 1401 |
Total Applications | 2620 |
Issued Applications | 2300 |
Pending Applications | 26 |
Abandoned Applications | 294 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 15697277
[patent_doc_number] => 10604808
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-31
[patent_title] => Marker for prenatal diagnosis and monitoring
[patent_app_type] => utility
[patent_app_number] => 15/842718
[patent_app_country] => US
[patent_app_date] => 2017-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 17
[patent_no_of_words] => 10778
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15842718
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/842718 | Marker for prenatal diagnosis and monitoring | Dec 13, 2017 | Issued |
Array
(
[id] => 16353408
[patent_doc_number] => 10793910
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-06
[patent_title] => Cystic fibrosis gene mutations
[patent_app_type] => utility
[patent_app_number] => 15/835836
[patent_app_country] => US
[patent_app_date] => 2017-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13186
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15835836
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/835836 | Cystic fibrosis gene mutations | Dec 7, 2017 | Issued |
Array
(
[id] => 15557597
[patent_doc_number] => 20200063210
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-27
[patent_title] => Gene Expression Signatures Associated with Patient Response to Acute Myeloid Leukemia Treatment and Use Thereof for Predicting Response to Therapy
[patent_app_type] => utility
[patent_app_number] => 16/466663
[patent_app_country] => US
[patent_app_date] => 2017-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12440
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16466663
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/466663 | Gene Expression Signatures Associated with Patient Response to Acute Myeloid Leukemia Treatment and Use Thereof for Predicting Response to Therapy | Dec 4, 2017 | Abandoned |
Array
(
[id] => 14899729
[patent_doc_number] => 20190293630
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-26
[patent_title] => METHODS AND KITS FOR PREDICTING CANCER PROGNOSIS AND METASTASIS
[patent_app_type] => utility
[patent_app_number] => 16/465991
[patent_app_country] => US
[patent_app_date] => 2017-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42981
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16465991
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/465991 | METHODS AND KITS FOR PREDICTING CANCER PROGNOSIS AND METASTASIS | Nov 30, 2017 | Abandoned |
Array
(
[id] => 12663913
[patent_doc_number] => 20180113137
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-26
[patent_title] => METHOD FOR DETECTING THE QUANTITY OF BIOMARKER AND IDENTIFYING DISEASE STATUS
[patent_app_type] => utility
[patent_app_number] => 15/821864
[patent_app_country] => US
[patent_app_date] => 2017-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6426
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 268
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15821864
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/821864 | METHOD FOR DETECTING THE QUANTITY OF BIOMARKER AND IDENTIFYING DISEASE STATUS | Nov 23, 2017 | Abandoned |
Array
(
[id] => 18117755
[patent_doc_number] => 11549137
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-10
[patent_title] => Determination of the genotype underlying the S-s-U-phenotype of the MNSs blood group system
[patent_app_type] => utility
[patent_app_number] => 16/462861
[patent_app_country] => US
[patent_app_date] => 2017-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9728
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16462861
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/462861 | Determination of the genotype underlying the S-s-U-phenotype of the MNSs blood group system | Nov 22, 2017 | Issued |
Array
(
[id] => 15621207
[patent_doc_number] => 20200081008
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-12
[patent_title] => METHODS FOR CANCER DETECTION
[patent_app_type] => utility
[patent_app_number] => 16/462699
[patent_app_country] => US
[patent_app_date] => 2017-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27568
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16462699
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/462699 | METHODS FOR CANCER DETECTION | Nov 21, 2017 | Abandoned |
Array
(
[id] => 13314911
[patent_doc_number] => 20180208992
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-26
[patent_title] => CpG ISLAND METHYLATION PROFILE IN NON-INVASIVE ORAL RINSE SAMPLES FOR DETECTION OF ORAL AND PHARYNGEAL CARCINOMA
[patent_app_type] => utility
[patent_app_number] => 15/806148
[patent_app_country] => US
[patent_app_date] => 2017-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4998
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15806148
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/806148 | CpG ISLAND METHYLATION PROFILE IN NON-INVASIVE ORAL RINSE SAMPLES FOR DETECTION OF ORAL AND PHARYNGEAL CARCINOMA | Nov 6, 2017 | Pending |
Array
(
[id] => 16305602
[patent_doc_number] => 10774381
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-15
[patent_title] => Genetic marker for determining meat quality traits of pigs and use thereof
[patent_app_type] => utility
[patent_app_number] => 15/804009
[patent_app_country] => US
[patent_app_date] => 2017-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 12
[patent_no_of_words] => 7964
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15804009
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/804009 | Genetic marker for determining meat quality traits of pigs and use thereof | Nov 5, 2017 | Issued |
Array
(
[id] => 12751381
[patent_doc_number] => 20180142294
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-24
[patent_title] => METHOD FOR AUTHENTICATING ACTIVE PHARMACEUTICAL INGREDIENTS
[patent_app_type] => utility
[patent_app_number] => 15/800768
[patent_app_country] => US
[patent_app_date] => 2017-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9828
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15800768
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/800768 | METHOD FOR AUTHENTICATING ACTIVE PHARMACEUTICAL INGREDIENTS | Oct 31, 2017 | Abandoned |
Array
(
[id] => 15769479
[patent_doc_number] => 20200115757
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2020-04-16
[patent_title] => TEST KITS AND METHODS FOR THEIR USE TO DETECT GENETIC MARKERS FOR UROTHELIAL CARCINOMA OF THE BLADDER AND TREATMENT THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/798922
[patent_app_country] => US
[patent_app_date] => 2017-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12536
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15798922
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/798922 | Test kits and methods for their use to detect genetic markers for urothelial carcinoma of the bladder and treatment thereof | Oct 30, 2017 | Issued |
Array
(
[id] => 15769479
[patent_doc_number] => 20200115757
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2020-04-16
[patent_title] => TEST KITS AND METHODS FOR THEIR USE TO DETECT GENETIC MARKERS FOR UROTHELIAL CARCINOMA OF THE BLADDER AND TREATMENT THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/798922
[patent_app_country] => US
[patent_app_date] => 2017-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12536
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15798922
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/798922 | Test kits and methods for their use to detect genetic markers for urothelial carcinoma of the bladder and treatment thereof | Oct 30, 2017 | Issued |
Array
(
[id] => 15210599
[patent_doc_number] => 20190367986
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-05
[patent_title] => GENE-SPECIFIC DNA METHYLATION CHANGES PREDICT REMISSION IN ANCA-ASSOCIATED VASCULITIS PATIENTS
[patent_app_type] => utility
[patent_app_number] => 16/341202
[patent_app_country] => US
[patent_app_date] => 2017-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14837
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16341202
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/341202 | GENE-SPECIFIC DNA METHYLATION CHANGES PREDICT REMISSION IN ANCA-ASSOCIATED VASCULITIS PATIENTS | Oct 10, 2017 | Abandoned |
Array
(
[id] => 15457341
[patent_doc_number] => 20200041495
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-06
[patent_title] => METHODS AND KITS FOR DETECTING A FUSION MESSENGER RNA TRANSCRIPT OR A POLYPEPTIDE ENCODED BY THE FUSION MESSENGER RNA TRANSCRIPT
[patent_app_type] => utility
[patent_app_number] => 16/338843
[patent_app_country] => US
[patent_app_date] => 2017-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17871
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16338843
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/338843 | Methods and kits for detecting a fusion messenger RNA transcript or a polypeptide encoded by the fusion messenger RNA transcript | Oct 5, 2017 | Issued |
Array
(
[id] => 12751429
[patent_doc_number] => 20180142310
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-24
[patent_title] => METHODS AND COMPOSITIONS FOR DETECTING ZIKA VIRUS IN SEMEN
[patent_app_type] => utility
[patent_app_number] => 15/723337
[patent_app_country] => US
[patent_app_date] => 2017-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19700
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15723337
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/723337 | Methods and compositions for detecting Zika virus | Oct 2, 2017 | Issued |
Array
(
[id] => 12138561
[patent_doc_number] => 20180016644
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-18
[patent_title] => 'METHOD FOR DETECTING METHYLATION OF COLORECTAL CANCER SPECIFIC METHYLATION MARKER GENE FOR COLORECTAL CANCER DIAGNOSIS'
[patent_app_type] => utility
[patent_app_number] => 15/710028
[patent_app_country] => US
[patent_app_date] => 2017-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 23009
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15710028
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/710028 | Method for detecting methylation of colorectal cancer specific methylation marker gene for colorectal cancer diagnosis | Sep 19, 2017 | Issued |
Array
(
[id] => 12233457
[patent_doc_number] => 20180066320
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-08
[patent_title] => 'DETECTING HEPATOCELLULAR CARCINOMA'
[patent_app_type] => utility
[patent_app_number] => 15/694300
[patent_app_country] => US
[patent_app_date] => 2017-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 47
[patent_figures_cnt] => 47
[patent_no_of_words] => 27605
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15694300
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/694300 | DETECTING HEPATOCELLULAR CARCINOMA | Aug 31, 2017 | Abandoned |
Array
(
[id] => 12126612
[patent_doc_number] => 20180010199
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-11
[patent_title] => 'PNA Probes, Probe Sets, Methods and Kits Pertaining to the Detection of Candida'
[patent_app_type] => utility
[patent_app_number] => 15/688485
[patent_app_country] => US
[patent_app_date] => 2017-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12894
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15688485
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/688485 | PNA probes, probe sets, methods and kits pertaining to the detection of candida | Aug 27, 2017 | Issued |
Array
(
[id] => 14582025
[patent_doc_number] => 20190218621
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-18
[patent_title] => USE OF GENOMIC SIGNATURES TO PREDICT RESPONSIVENESS OF PATIENTS WITH PROSTATE CANCER TO POST-OPERATIVE RADIATION THERAPY
[patent_app_type] => utility
[patent_app_number] => 16/327260
[patent_app_country] => US
[patent_app_date] => 2017-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31012
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16327260
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/327260 | Use of genomic signatures to predict responsiveness of patients with prostate cancer to post-operative radiation therapy | Aug 23, 2017 | Issued |
Array
(
[id] => 12219521
[patent_doc_number] => 20180057880
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-01
[patent_title] => 'METHODS, COMPOSITIONS, AND DIAGNOSTIC KITS FOR THE DETECTION OF ALPHA AND BETA THALASSEMIA'
[patent_app_type] => utility
[patent_app_number] => 15/684281
[patent_app_country] => US
[patent_app_date] => 2017-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 20605
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15684281
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/684281 | Methods, compositions, and diagnostic kits for the detection of alpha and beta thalassemia | Aug 22, 2017 | Issued |